Overexpression of B‐cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response-Reference-Cited by-同舟云学术

Overexpression of B‐cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response

Published:2017-06-25 Issue:8 Volume:108 Page:1556-1564
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Tahara Kenichi¹^ORCID,Takizawa Makiko¹,Yamane Arito¹,Osaki Yohei¹,Ishizaki Takuma¹,Mitsui Takeki¹,Yokohama Akihiko²,Saitoh Takayuki³,Tsukamoto Norifumi⁴,Matsumoto Morio⁵,Murakami Hirokazu³,Nojima Yoshihisa¹,Handa Hiroshi¹

Affiliation:

1. Department of Medicine and Clinical Science Gunma University Graduate School of Medicine GunmaJapan

2. Division of Blood Transfusion Service Gunma University Hospital GunmaJapan

3. Department of Laboratory Sciences Gunma University Graduate School of Health Sciences GunmaJapan

4. Oncology Center Gunma University Hospital GunmaJapan

5. Department of Hematology National Hospital Organization Nishigunma National Hospital Gunma Japan

Funder

Grant-in-Aid for Scientific Research

National Cancer Research and Development Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13283

Reference45 articles.

1. Multiple myeloma: evolving genetic events and host interactions

2. Genomic instability in multiple myeloma: mechanisms and therapeutic implications

3. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma

4. Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability

5. Dendritic cell–mediated activation-induced cytidine deaminase (AID)–dependent induction of genomic instability in human myeloma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival;OncoTargets and Therapy;2022-12

2. B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas;Journal of Medicinal Chemistry;2022-11-28

3. My Journey from Hematology to Healthcare Quality and Safety;The Kitakanto Medical Journal;2020-05-01

4. Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth;Journal of Medicinal Chemistry;2020-01-02

5. Germline Risk Contribution to Genomic Instability in Multiple Myeloma;Frontiers in Genetics;2019-05-08